Cardiovascular consequences of hormone therapy in postmenopausal women: Messages to clinicians

gan YLIKORKALA, O., MIKKOLA, T.
Cyhoeddwyd yn Reprod Med Biol (2005)

Thromboxane A2 in pregnancy and puerperium.

gan Ylikorkala, O, Viinikka, L
Cyhoeddwyd 1980

Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.

gan Venesmaa, P., Ylikorkala, O.
Cyhoeddwyd 1991

Effect of various doses of acetylsalicylic acid in combination with dipyridamole on the balance between prostacyclin and thromboxane in human serum.

gan Viinikka, L., Ylikorkala, O.
Cyhoeddwyd 1981

Concentrations of zinc and copper in pregnant problem drinkers and their newborn infants.

gan Halmesmaki, E, Ylikorkala, O, Alfthan, G
Cyhoeddwyd 1985

The effect of prolonged treatment with sulphinpyrazone on thromboxane A2 and prostacyclin in man.

gan Viinikka, L, Toivanen, J, Ylikorkala, O
Cyhoeddwyd 1982

Prostacyclin and thromboxane in diabetes.

gan Ylikorkala, O, Kaila, J, Viinikka, L
Cyhoeddwyd 1981

Raised serum human chorionic gonadotrophin concentrations in hyperemesis gravidarum.

gan Kauppila, A, Huhtaniemi, I, Ylikorkala, O
Cyhoeddwyd 1979

Plasma prostacyclin from birth to adolescence.

gan Kääpä, P, Viinikka, L, Ylikorkala, O
Cyhoeddwyd 1982

Fetal and neonatal prostacyclin and thromboxane in relation to mode of delivery.

gan Ylikorkala, O, Pohjavuori, M, Rovamo, L
Cyhoeddwyd 1986

Sulpiride improves inadequate lactation.

gan Ylikorkala, O, Kauppila, A, Kivinen, S, Viinikka, L
Cyhoeddwyd 1982

Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.

gan Aitokallio-Tallberg, A., Viinikka, L., Ylikorkala, O.
Cyhoeddwyd 1989

Neonatal respiratory distress caused by aspiration of a vaginal tablet containing prostaglandin.

gan Andersson, S, Paetau, R, Hallman, M, Vapaatalo, H, Ylikorkala, O
Cyhoeddwyd 1987

Effect of interleukin 2 on urinary excretion of degradation products of prostacyclin and thromboxane A2 in patients with ovarian cancer.

gan Aitokallio-Tallberg, A., Lehtovirta, P., Vartiainen, J., Ylikorkala, O.
Cyhoeddwyd 1995

Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate.

gan Aitokallio-Tallberg, A., Kärkkäinen, J., Pantzar, P., Wahlström, T., Ylikorkala, O.
Cyhoeddwyd 1985

Urinary epidermal growth factor concentrations in various human malignancies.

gan Mattila, A. L., Saario, I., Viinikka, L., Ylikorkala, O., Perheentupa, J.
Cyhoeddwyd 1988

Human vascular endothelial cells produce TNF-α after stimulation with proinflammatory cytokines

gan Ranta, V, Orpana, A, Carpén, O, Turpeinen, U, Ylikorkala , O, Viinikka, L
Cyhoeddwyd 1999

Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.

gan Venesmaa, P., Lehtovirta, P., Stenman, U. H., Leminen, A., Forss, M., Ylikorkala, O.
Cyhoeddwyd 1994

Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women

gan Marttunen, M B, Cacciatore, B, Hietanen, P, Pyrhönen, S, Tiitinen, A, Wahlström, T, Ylikorkala, O
Cyhoeddwyd 2001

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy

gan Goldstein, S. R., Bachmann, G. A., Koninckx, P. R., Lin, V. H., Portman, D. J., Ylikorkala, O.
Cyhoeddwyd 2014